Motorists could be slapped with fines of up to £1,000 if they fail to tell the DVLA about certain health conditions that ...

The Diabetes Prevention Program is entering its second series of Lifestyle Change Program classes to help people with ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

A small study found that drinking ketones improved heart efficiency in type 2 diabetes patients, supporting the hypothesis ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Medical experts said such an innovative monitoring method, may significantly enhance patients' compliance to blood glucose monitoring regularly and improve their quality of life.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...